Search Within

Maria Irene Rodriguez-Sanchez

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
Groups
  1. CTCR Scholars (10)
  2. Center for Hematologic Malignancies (10)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (10)
  4. GSK Faculty (10)
  5. MSK Grad Students (10)
  6. Master of Science in Clinical and Translational Cancer Research (10)

More Groups

People
  1. Parastoo Dahi (7)
  2. Richard O'Reilly (7)
  3. Susan Prockop (7)
  4. Ekaterina Doubrovina (6)
  5. Aisha Hasan (4)
  6. Audrey Mauguen (4)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (1)
  4. 2020 (2)
  5. 2017 (2)
  6. 2016 (1)
Publications
  1. Blood (2)
  2. Bone Marrow Transplantation (2)
  3. Cancer Research (2)
  4. Biology of Blood and Marrow Transplantation (1)
  5. Blood Advances (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. American Society of Hematology (3)
  2. Nature Publishing Group (3)
  3. American Association for Cancer Research (2)
  4. American Society for Clinical Investigation (1)
  5. Elsevier Inc. (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Subclonal somatic copy-number alterations emerge and dominate in recurrent osteosarcoma
    Journal Article

    Kinnaman, M. D.; Zaccaria, S.; Makohon-Moore, A.; Arnold, B.; Levine, M. F.; Gundem, G.; Arango Ossa, J. E.; Glodzik, D.; Rodríguez-Sanchez, M. I.; Bouvier, N.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
    Journal Article

    Prockop, S. E.; Hasan, A.; Doubrovina, E.; Dahi, P. B.; Rodriguez-Sanchez, I.; Curry, M.; Mauguen, A.; Papanicolaou, G. A.; Su, Y.; Yao, J.; more...
    Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
    Meeting Abstract

    Dela Cruz, F. S.; McCarter, J. G.; You, D.; Bouvier, N.; Wang, X.; Guillan, K. C.; Siddiquee, A. H.; Souto, K. B.; Li, H.; Gao, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers
    Journal Article

    Shukla, N.; Levine, M. F.; Gundem, G.; Domenico, D.; Spitzer, B.; Bouvier, N.; Arango-Ossa, J. E.; Glodzik, D.; Medina-Martínez, J. S.; Bhanot, U.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4(+) immunity to mediate durable responses
    Journal Article

    Fabrizio, V. A.; Rodriguez-Sanchez, M. I.; Mauguen, A.; Dahi, P. B.; Doubrovina, E.; O'Reilly, R. J.; Prockop, S. E.
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV CTLS for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P.; Doubrovina, E.; O'Reilly, R. J.; Prockop, S.
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV cytotoxic T-Cells for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P. B.; O'Reilly, R. J.; Prockop, S. E.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Five years of therapy with donor and 3rd party derived EBV and CMV specific cytotoxic T cells - Safety after more than 1,000 infusions
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; Koehne, G.; Dahi, P.; Papadopoulos, E.; Sauter, C.; Rodriguez-Sanchez, I.; Suser, S.; Escobedo, V.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Third party CMV-specific cytotoxic T cells for treatment of antiviral resistant CMV infection after hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A. N.; Dahi, P. B.; Giralt, S.; Koehne, G.; Kernan, N. A.; Papadopoulos, E. B.; Lehrman, R.; Rodriguez-Sanchez, I.; more...
    Blood (2016)

    Fulltext@MSK | Save